Dolby Laboratories (NYSE:DLB) Issues FY 2025 Earnings Guidance

Dolby Laboratories (NYSE:DLB) updated its FY 2025 earnings guidance on Tuesday. The company provided EPS guidance of 3.990-4.140 for the period, compared to the consensus EPS estimate of 3.700. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.3 billion. Dolby Laboratories also updated its FY25 guidance to $2.43-2.58 EPS.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. StockNews.com raised Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research report on Monday. Barrington Research reaffirmed an “outperform” rating and set a $100.00 target price on shares of Dolby Laboratories in a research report on Friday, September 20th.

Dolby Laboratories Stock Down 0.6 %

NYSE DLB traded down $0.42 on Tuesday, reaching $70.93. The company had a trading volume of 416,799 shares, compared to its average volume of 396,175. The stock has a market capitalization of $6.76 billion, a P/E ratio of 32.38 and a beta of 0.98. The company’s fifty day moving average is $73.66 and its 200 day moving average is $76.09. Dolby Laboratories has a 52-week low of $66.35 and a 52-week high of $90.06.

Dolby Laboratories announced that its board has approved a share repurchase plan on Wednesday, August 7th that authorizes the company to repurchase $350.00 million in shares. This repurchase authorization authorizes the electronics maker to repurchase up to 5% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s management believes its stock is undervalued.

Insider Activity at Dolby Laboratories

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 28,512 shares of the company’s stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $74.12, for a total value of $2,113,309.44. Following the completion of the transaction, the chief executive officer now owns 83,721 shares in the company, valued at $6,205,400.52. This represents a 25.40 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 39.54% of the stock is currently owned by insiders.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.